Join
Live feed
·
INSIDERFilingvia Quantisnow
Concert Pharmaceuticals Inc. logo

SEC Form 4: Becker Marc A. sold $9,261 worth of shares (2,894 units at $3.20) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 61,173 units (tax liability)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CNCE (Concert Pharmaceuticals Inc.) and more on Quantisnow.